Included below are news items from the last six months.
Celebrating the work of Pathology
National Pathology Week taking place between 3-9 November 2014, is designed to raise awareness of laboratory medicine and give members of the public the opportunity to meet the team behind the scenes and gain a greater understanding of pathology.
Lab Tests Online-UK (LTOL-UK) is delighted to be celebrating our 10 year anniversary at EuroLabFocus. This international meeting, being held in Liverpool between 7 – 10 October 2014, is the third joint conference of the Union of European Medical Specialists (UEMS) and the European Federation of Clinical Chemistry & Laboratory Medicine (EFLM), hosted by The Association for Clinical Biochemistry and Laboratory Medicine, and incorporating Focus 2014. The scientific programme focuses on laboratory medicine's practice and contribution to health and healthcare across Europe.
William Kremer has written an interesting article in the BBC News Magazine with the title ‘Do doctors understand test results?’. It is based on a new book ‘Risk Savvy’ by controversial psychologist Gerd Gigerenzer that also deals with such topics as the risks of stock market crashes and of travelling by plane. Kremer’s article gives examples of the mistaken interpretation of screening test results that should interest both doctors and patients.
On the 9th of June 2014, NHS England issued a patient safety alert to clinical laboratories recommending the implementation of a standardised algorithm to detect acute kidney injury (AKI). The alert provides a standardised version of the algorithm to ensure the same practice is used across all NHS laboratories in England and is aimed to reducing the damage caused by delayed recognition of the condition.
Between 60 and 80% of patients taken to hospital with chest pain are found not to have had a heart attack. In a news item on 20 November 2011 we reported that a rapid "rule out" blood test appeared to hold promise of making hospital admission unnecessary for many patients. The National Institute for Health and Care Excellence (NICE) has reviewed recent evidence, and on 16 May 2014 published draft guidance that the use of high-sensitivity cardiac troponin could mean a reduced length of hospital stay for people with a normal result, and earlier treatment for those patients with an abnormal troponin result. Following consultation, NICE plans to publish final guidance in October 2014.